共 22 条
- [1] Agy M.B., Frumkin K.R., Corey L., Coombs M., Wolinsky S.M., Koehler J., Morton W.R., Katze M.G., Infection of Macaca nemestrina by human immunodeficiency virus type-1, Science, 257, pp. 103-106, (1992)
- [2] Berman P., Gregory T., Riddle L., Nakamura G., Champe M., Porter J., Wurm F., Hershberg R., Cobb E.K., Eichberg J., Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160, Nature, 345, pp. 622-625, (1990)
- [3] Brodsky F.M., Parham P., Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants, J. Immunol, 128, pp. 129-135, (1982)
- [4] Cheng-Mayer C., Quiroga M., Tung J.W., Dina D., Levy J.A., Viral determinants of human immunodeficiency virus type 1 T-ceil or macrophage tropism, cytopathogenicity and CD4 antigen modulation, J. Virol, 64, pp. 4390-4398, (1990)
- [5] Emini E.A., Schleif W.A., Nunberg J.H., Conley A.J., Eda Y., Toki-Yoshi S., Putney S.D., Matsushita S., Cobb K.E., Iett C.M., Eichberg J.W., Murthy K.K., Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody, Nature, 355, pp. 728-730, (1992)
- [6] Fultz P.N., McClure H.M., Swenson R.B., McGrath C.R., Brodie A., Getchell J.P., Jensen F.C., Erson D.C., Broderson J.R., Francis D.P., Persistent infection of chimpanzees with human T'lymphotropic virus type lll/lymphadenopathy-associated virus: A potential model for acquired immunodeficiency syndrome, i, Virol, 58, pp. 116-124, (1986)
- [7] Girard M., Kieny M.P., Pinter A., Barre-Sinoussi F., Nara P., Kolbe H., Kusumi K., Chaput A., Reinhart T., Muchmore E., Ronco J., Kaczorek M., Gomard E., Gluckman J.C., Fultz P.N., Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus, Proc. Natl. Acad. Set. USA, 88, pp. 542-546, (1991)
- [8] Gotch F.M., Kelly C., Ellis S.A., Wallace F., Rickinson A.B., Van Der Poel J., Crumpton M.J., McMichael A.J., Characterization of the FU A2.2 subtype. T cell evidence for further heterogeneity, Immunogenetics, 21, pp. 11-23, (1985)
- [9] Hirsch V.M., Martin J.E., Dapolito G., Elkins W.R., London W.T., Goldstein S., Johnson P., Spontaneous substitutions in the vicinity of the "V3 analog" affect cell tropism and pathogenicity of simian immunodeficiency virus, J. Virol, 68, pp. 2649-2661, (1994)
- [10] Javaherian K., Langlois A., Schmidt S., Kaufman M., Cates J., Langedijk N., Meloen R., Desrosiers R., Burns D., Bolognesi D., Larosa G., Putney S., The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus, Proc. Natl. Acad Sci. USA, 89, pp. 1418-1422, (1992)